There are 2789 resources available
591P - A first-in-human study of FOR46 in men with metastatic castration resistant prostate cancer (mCRPC)
Presenter: Rahul Aggarwal
Session: ePoster Display
713P - Assessment of bleomycin pulmonary toxicity in men with poor-prognosis non-seminomatous germ-cell tumors treated in the GETUG 13 phase III trial
Presenter: Natacha Naoun
Session: ePoster Display
687P - NIVOREN GETUG-AFU 26 translational study: Baseline peripheral cytokines predict survival in metastatic clear cell renal carcinoma (RCC) treated with nivolumab
Presenter: Lucia Carril Ajuria
Session: ePoster Display
558TiP - Phase I study of effector-function enhanced monoclonal antibody (mAb), SEA-TGT, in advanced malignancies
Presenter: Vincent Ribrag
Session: ePoster Display
559TiP - A phase II study of TAS-117 in patients with advanced solid tumors harboring germline PTEN inactivating mutations
Presenter: Jordi Rodon
Session: ePoster Display
560TiP - A phase I/IIa study to evaluate the safety and efficacy of CCS1477, a first in clinic inhibitor of p300/CBP, as monotherapy in patients with selected molecular alterations
Presenter: Simon Crabb
Session: ePoster Display
561TiP - A phase I dose-escalation study of ZN-d5, an BCL-2 inhibitor with improved selectivity, in patients with advanced non-Hodgkin lymphoma (NHL) or acute myeloid leukemia (AML)
Presenter: Jan Zaucha
Session: ePoster Display